INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Price, Forecast & Analysis
NYSE:INSP • US4577301090
INSP Key Statistics, Chart & Performance
The current stock price of INSP is 64.51 USD. In the past month the price decreased by -17.86%. In the past year, price decreased by -65.24%.
INSP Technical Analysis
INSP Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to INSP. INSP has an excellent financial health rating, but there are some minor concerns on its profitability.
INSP Financial Highlights
Over the last trailing twelve months INSP reported a non-GAAP Earnings per Share(EPS) of 2.51. The EPS increased by 45.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.05% | ||
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| Debt/Equity | 0 |
INSP Forecast & Estimates
25 analysts have analysed INSP and the average price target is 95.55 USD. This implies a price increase of 48.11% is expected in the next year compared to the current price of 64.51.
For the next year, analysts expect an EPS growth of -29.76% and a revenue growth 7.01% for INSP
INSP Ownership
INSP Latest News, Press Relases and Analysis
INSP Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 20.26 | 202.161B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.26 | 178.812B | ||
| SYK | STRYKER CORP | 25.62 | 148.172B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.94 | 112.339B | ||
| IDXX | IDEXX LABORATORIES INC | 44.32 | 52.44B | ||
| BDX | BECTON DICKINSON AND CO | 11.2 | 50.332B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.08 | 49.848B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.78 | 38.246B | ||
| RMD | RESMED INC | 20.87 | 37.332B | ||
| DXCM | DEXCOM INC | 29.08 | 29.01B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About INSP
Company Profile
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Company Info
INSPIRE MEDICAL SYSTEMS INC
5500 Wayzata Blvd Ste 1600
Golden Valley MINNESOTA 55416 US
CEO: TimothyP. Herbert
Employees: 1246
Phone: 17639575037
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What does INSPIRE MEDICAL SYSTEMS INC do?
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Can you provide the latest stock price for INSPIRE MEDICAL SYSTEMS INC?
The current stock price of INSP is 64.51 USD. The price decreased by -5.2% in the last trading session.
Does INSPIRE MEDICAL SYSTEMS INC pay dividends?
INSP does not pay a dividend.
What is the ChartMill technical and fundamental rating of INSP stock?
INSP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the market expecting INSP stock to perform?
25 analysts have analysed INSP and the average price target is 95.55 USD. This implies a price increase of 48.11% is expected in the next year compared to the current price of 64.51.
What is the GICS sector and industry of INSP stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the market cap for INSPIRE MEDICAL SYSTEMS INC?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a market capitalization of 1.87B USD. This makes INSP a Small Cap stock.